Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New data strategy aims to boost HIV suppression in underserved communities

NCT ID NCT05140421

Disease control Sponsor: City University of New York Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a 'data-to-suppression' approach to help people with HIV who are not virally suppressed. It uses reports to guide support services for about 1,500 low-income individuals in New York City. The goal is to improve viral suppression rates and reduce health disparities.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

1,494 people

The number who actually took part.

Started

Dec 2021

Expected to finish

Apr 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * For each stepped-wedge implementation period (Period 0, 1, or 2), clients eligible for trial inclusion must have: (1) ≥1 viral load (VL) test in the report year (evidence that they are in HIV care in NYC); (2) unsuppressed VL (≥200 copies/mL) at last reported VL test during that year; and (3) a reported service in one of the eligible programs/agencies during the report year. In addition, they must still have an open RWPA enrollment in one of the eligible programs and agencies and be presumed living at the time of report generation (two months following the end of the report year on which data are being shared with providers). Exclusion Criteria: * Agencies without current NYC RWPA funding for housing assistance or behavioral health (mental health, supportive counseling or harm reduction) services are excluded. Agencies with \<5 clients meeting the above inclusion criteria over three recent pre-implementation sample periods of data are also excluded (due to insufficient numbers of unsuppressed clients). Clients enrolled in NYC RWPA behavioral health or housing programs are excluded from the trial if they are virally suppressed, deceased, or lacking any evidence of NYC HIV care for a full year at the time a D2S report is issued. Given the potential lag in reporting to surveillance and the need to use the freshest available surveillance data for D2S reports, some clients may later be found to have died or to have a VL\<200 dated after their qualifying VL≥200 but prior to D2S report generation; such clients will be excluded post hoc from that round of follow-up due to VS at the time of intervention. Similarly, clients later reported (in programmatic data) to have been closed out of all eligible programs before the report issue date will be excluded post hoc.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

AIDS HIV infectious disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIV

Contacts and locations

Locations

  • AIDS Center of Queens County, Inc.

    New York, New York, 11432, United States

  • African Services Committee, Inc.

    New York, New York, 10027, United States

  • After Hours Project

    New York, New York, 11221, United States

  • Alliance for Positive Change

    New York, New York, 10001, United States

  • Bailey House, Inc.

    New York, New York, 10035, United States

  • Boom!Health

    New York, New York, 10451, United States

  • Bridging Access to Care, Inc.

    New York, New York, 11216, United States

  • BronxWorks, Inc.

    New York, New York, 10453, United States

  • CAMBA, Inc.

    New York, New York, 11226, United States

  • Exponents, Inc.

    New York, New York, 10004, United States

  • GMHC

    New York, New York, 10018, United States

  • Harlem United

    New York, New York, 10027, United States

  • Housing Works

    New York, New York, 11201, United States

  • Interfaith Medical Center

    New York, New York, 11213, United States

  • La Nueva Esperanza, Inc.

    New York, New York, 11206, United States

  • Mount Sinai Beth Israel

    New York, New York, 10003, United States

  • NYC Health and Hospitals Harlem

    New York, New York, 10037, United States

  • NYC Health and Hospitals Queens

    New York, New York, 11432, United States

  • NYC Health and Hospitals Woodhull

    New York, New York, 11206, United States

  • New York Harm Reduction Educators, Inc.

    New York, New York, 10035, United States

  • New York Presbyterian Hospital

    New York, New York, 10032, United States

  • Planned Parenthood of Greater New York

    New York, New York, 11225, United States

  • Project Hospitality, Inc.

    New York, New York, 10302, United States

  • Research Foundation of State University of New York

    New York, New York, 11203, United States

  • St. Ann's Corner of Harm Reduction

    New York, New York, 10459, United States

  • The Institute for Family Health

    New York, New York, 10035, United States

  • Tolentine Zeiser Community Life Center

    New York, New York, 10463, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.